Caroline Wishart
About Caroline Wishart
Caroline Wishart serves as the VP Finance and Controller at Generate Biomedicines, specializing in the finance continuum with over 20 years of experience in the biotech sector. She has held various leadership roles at Vertex Pharmaceuticals and has a strong background in accounting and finance.
Current Role at Generate Biomedicines
Caroline Wishart serves as the Vice President of Finance and Controller at Generate Biomedicines. She has held this position since 2022. In this role, she specializes in the finance continuum, which includes forecasting, budget processes, closing the books, and external reporting. Her expertise contributes to the financial management and strategic planning of the organization.
Previous Experience at Vertex Pharmaceuticals
Prior to her current role, Caroline Wishart worked at Vertex Pharmaceuticals in various capacities. She served as Vice President of Accounting from 2015 to 2019 and as Vice President of Commercial and G&A Finance from 2019 to 2022. Additionally, she was a Senior Director of Accounting at Vertex from 2013 to 2015. Her tenure at Vertex spanned nearly seven years, during which she developed a comprehensive understanding of financial operations in the biotech sector.
Professional Background in Accounting
Caroline Wishart began her career as an Auditor at EY, where she worked from 2000 to 2004. This role provided her with foundational skills in accounting and auditing practices. Her extensive experience in the finance sector, exceeding 20 years, has equipped her with the knowledge necessary to navigate complex financial landscapes.
Education and Qualifications
Caroline Wishart earned her Bachelor's degree in Economics from Colgate University, where she studied from 1995 to 1999. She furthered her education by obtaining a Master of Business Administration (MBA) with a focus on Accounting from Northeastern University in 2000. Her academic background supports her expertise in finance and accounting.
Specialization in Finance
Caroline Wishart specializes in the finance continuum, focusing on forecasting, budget processes, closing the books, and external reporting. She is recognized for her direct approach that produces results and fosters cross-functional partnerships. Her leadership style emphasizes team-building and practical solutions, which are essential in the biotech financial sector.